Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Inhibition of peptidyl-arginine deiminases reverses protein-hypercitrullination and disease in mouse models of multiple sclerosis.
Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.
Clostridia as agents of zoonotic disease.
Sex ratio of infectious mononucleosis and possible relevance to multiple sclerosis.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation.
Audit on intravenous immunoglobulin (ivig) use in aberdeen royal infirmary neurology department according to 2005 association of british neurologists (abn) guidelines.
Multiple sclerosis as a cause of the acute vestibular syndrome.
Poppers toxic maculopathy misdiagnosed as atypical optic neuritis.
Downbeat nystagmus associated with damage to the medial longitudinal fasciculus of the pons: A vestibular balance control mechanism via the lower brainstem paramedian tract neurons.
The antibody response to Epstein-Barr virions is altered in multiple sclerosis.
Purification and biological characterization of soluble, recombinant mouse IFNβ expressed in insect cells.
Intrinsic and extrinsic control of oligodendrocyte development.
[Ophthalmological Findings in Paediatric and Adolescent Multiple Sclerosis.]
The Lateral Membrane Organization and Dynamics of Myelin Proteins PLP and MBP Are Dictated by Distinct Galactolipids and the Extracellular Matrix.
Experience with Fingolimod in Clinical Practice.
Dissection of a Complex Disease Susceptibility Region Using a Bayesian Stochastic Search Approach to Fine Mapping.
Comparison of the 2010 and 2005 versions of the McDonald MRI criteria for dissemination-in-time in Taiwanese patients with classic multiple sclerosis.
Thymic peptides restrain the inflammatory response in mice with experimental autoimmune encephalomyelitis.
Comparison of the effect of baclofen and transcutaneous electrical nerve stimulation for the treatment of spasticity in multiple sclerosis.
Merck Serono and Opexa Therapeutics Enter into Option and License Agreement for Development of Tcelna™ (imilecleucel-T) for Treatment of Multiple Sclerosis
A novel method for calculating prevalence of multiple sclerosis in Australia.
Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate-Mediated Excitotoxicity.
Kynurenines in the CNS: recent advances and new questions.
Progressive multifocal leukoencephalopathy associated to natalizumab extended dosing regimen.

Pages